Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 59651-104

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 59651-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Eletriptan Fig1)

A line graph showing the estimated probability of response over time, from 0 to 2 hours after initial dose. The graph compares response probabilities for double blind placebo and Eletriptan Hydrobromide at 20 mg, 40 mg, and 80 mg doses, with the 40 mg and 80 mg doses showing higher response rates than placebo over time.*

FDA Label Image

Figure2 (Eletriptan Fig2)

A line graph showing the probability of a second dose or other medication use over time in hours, starting from the initial dose. The graph includes data for double blind placebo and Eletriptan at doses 20 mg, 40 mg, and 80 mg, each represented by distinct line markers. The y-axis is labeled as the probability of second dose or other medication use, ranging from 0 to 0.9, and the x-axis represents time from initial dose in hours, ranging from 0 to 24 hours.*

FDA Label Image

Package Label-principal Display Panel-20 mg (1x6) Carton (Eletriptan Fig3)

Packaging label for Eletriptan Hydrobromide tablets, 20 mg strength, film-coated oral tablets. The label indicates a package size of 6 unit-dose tablets. The product is marked for prescription use only and is distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (40 mg (1x6) Carton)

Packaging label for Eletriptan Hydrobromide Tablets 40 mg film-coated tablets, distributed by Aurobindo Pharma USA, Inc. The carton contains 6 unit-dose packages of 1x6 tablets each. The label features the product name, strength, NDC 59651-105-69, child-resistant packaging information, storage temperature guideline, and manufacturer details. The design includes the Aurobindo logo and a barcode.*

FDA Label Image

Chemical Structure (Eletriptan Str)

Chemical structure diagram of eletriptan hydrobromide, showing its molecular components including aromatic rings, sulfonyl, and amine groups along with the hydrobromide salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.